HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masamichi Sugimoto Selected Research

Masamichi Sugimoto Research Topics

Disease

15Neoplasms (Cancer)
11/2023 - 12/2008
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 02/2015
3Hepatocellular Carcinoma (Hepatoma)
11/2010 - 01/2009
2Brain Neoplasms (Brain Tumor)
01/2022 - 01/2020
2Neoplasm Metastasis (Metastasis)
01/2022 - 01/2020
2Disease Progression
09/2019 - 01/2017
2Liver Neoplasms (Liver Cancer)
05/2009 - 12/2008
2Lymphoma (Lymphomas)
12/2004 - 11/2002
1Adenocarcinoma of Lung
01/2023
1Breast Neoplasms (Breast Cancer)
09/2022
1Pneumonia (Pneumonitis)
12/2021
1Ovarian Neoplasms (Ovarian Cancer)
09/2019
1Carcinoma (Carcinomatosis)
09/2019
1Multiple Myeloma
10/2010
1Leukemia
12/2004
1Rheumatoid Arthritis
06/2003
1Acquired Immunodeficiency Syndrome (AIDS)
11/2002

Drug/Important Bio-Agent (IBA)

6Bevacizumab (Avastin)FDA Link
09/2022 - 01/2017
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 06/2003
5AntibodiesIBA
02/2022 - 01/2009
4GlypicansIBA
11/2010 - 12/2008
3B7-H1 AntigenIBA
11/2023 - 01/2022
3Immune Checkpoint InhibitorsIBA
01/2023 - 01/2021
3codrituzumabIBA
11/2010 - 12/2008
2Therapeutic UsesIBA
11/2023 - 04/2019
2ChemokinesIBA
02/2022 - 04/2019
2LigandsIBA
02/2022 - 01/2021
2Immunoglobulin G (IgG)IBA
01/2022 - 01/2020
2Paclitaxel (Taxol)FDA LinkGeneric
09/2019 - 01/2017
2Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2017 - 02/2015
2ErbB Receptors (EGF Receptor)IBA
08/2017 - 02/2015
2Tyrosine Kinase InhibitorsIBA
08/2017 - 02/2015
2Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
11/2010 - 01/2009
2Monoclonal AntibodiesIBA
11/2010 - 10/2010
2Interleukin-6 (Interleukin 6)IBA
06/2003 - 11/2002
1naringinIBA
11/2023
1RNA (Ribonucleic Acid)IBA
01/2023
1Indicators and Reagents (Reagents)IBA
01/2023
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2023
1palbociclibIBA
09/2022
1Hormones (Hormone)IBA
09/2022
1Growth Factor ReceptorsIBA
09/2022
1atezolizumabIBA
12/2021
1Angiogenesis InhibitorsIBA
01/2021
1liposomal doxorubicin (Doxil)FDA Link
09/2019
1Insulin-Like PeptidesIBA
09/2019
1Cisplatin (Platino)FDA LinkGeneric
04/2019
1Immune Checkpoint ProteinsIBA
04/2019
1Irinotecan (Camptosar)FDA LinkGeneric
07/2018
1Folic Acid (Vitamin M)FDA LinkGeneric
07/2018
1onartuzumabIBA
02/2015
1Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
11/2010
1Bone Marrow Stromal Antigen 2IBA
10/2010
1CarbohydratesIBA
12/2008
1Antineoplastic Agents (Antineoplastics)IBA
12/2008
1MitogensIBA
12/2004

Therapy/Procedure

8Therapeutics
11/2023 - 06/2003
3Immunotherapy
11/2023 - 01/2021
3Drug Therapy (Chemotherapy)
09/2022 - 09/2019
1Aftercare (After-Treatment)
09/2022
1Combination Drug Therapy (Combination Chemotherapy)
01/2017